Clinical Trials and the Independence of Investigators: A Novel Method for the Conduct of Pharmaceutical Company-Funded Clinical Drug Trials Which Ensures Investigator Independence

Author： Beran Roy G.   Ainley Laetitia A.E.   Beran Maureen E.  

Publisher： Adis International

ISSN： 1364-9027

Source： International Journal of Pharmaceutical Medicine, Vol.19, Iss.5-6, 2005-01, pp. : 309-316

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Investigator barriers and preferences to conduct clinical drug trials in Finland: a qualitative study

By Keinonen T.   Keränen T.   Klaukka T.   Saano V.   Ylitalo P.   Enlund H.  

Pharmacy World and Science, Vol. 25, Iss. 6, 2003-12 ,pp. : 251-259

Springer Publishing Company

Access to resources Recommend Favorite

Post-Launch Clinical Investigator Drug Prescribing in the US: The Behaviour of Clinical Trial Investigators after Participating in Phase III Trials

By Glass Harold E.   Rosenthal Bruce  

International Journal of Pharmaceutical Medicine, Vol. 19, Iss. 2, 2005-01 ,pp. : 97-104

Adis International

Access to resources Recommend Favorite

Enhancing Trial Integrity by Protecting the Independence of Data Monitoring Committees in Clinical Trials

By        

Journal of Biopharmaceutical Statistics, Vol. 24, Iss. 5, 2014-09 ,pp. : 968-975

Taylor & Francis Ltd

Access to resources Recommend Favorite

Clinical Trials Research in Pediatrics: Strategies for Effective Collaboration Between Investigator Sites and the Pharmaceutical Industry

By Bush Andrew  

Pediatric Drugs, Vol. 8, Iss. 5, 2006-01 ,pp. : 271-277

Adis International

Access to resources Recommend Favorite

The contemporary situation for the conduct of clinical trials in Asia

By CG F.   E W.   D Z.  

International Journal of Pharmaceutical Medicine, Vol. 15, Iss. 4, 2001-08 ,pp. : 169-173

Adis International

Access to resources Recommend Favorite